6RHW image
Deposition Date 2019-04-23
Release Date 2019-12-18
Last Version Date 2024-01-24
Entry Detail
PDB ID:
6RHW
Keywords:
Title:
Crystal structure of human CD11b I-domain (CD11b-I) in complex with Staphylococcus aureus octameric bi-component leukocidin LukGH
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.75 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.24
Space Group:
P 4 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Integrin alpha-M
Gene (Uniprot):ITGAM
Chain IDs:C
Chain Length:195
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Beta-channel forming cytolysin
Chain IDs:A (auth: G)
Chain Length:309
Number of Molecules:1
Biological Source:Staphylococcus aureus
Polymer Type:polypeptide(L)
Molecule:Beta-channel forming cytolysin
Chain IDs:B (auth: H)
Chain Length:324
Number of Molecules:1
Biological Source:Staphylococcus aureus
Primary Citation
Molecular mechanism of leukocidin GH-integrin CD11b/CD18 recognition and species specificity.
Proc.Natl.Acad.Sci.USA 117 317 327 (2020)
PMID: 31852826 DOI: 10.1073/pnas.1913690116

Abstact

Host-pathogen interactions are central to understanding microbial pathogenesis. The staphylococcal pore-forming cytotoxins hijack important immune molecules but little is known about the underlying molecular mechanisms of cytotoxin-receptor interaction and host specificity. Here we report the structures of a staphylococcal pore-forming cytotoxin, leukocidin GH (LukGH), in complex with its receptor (the α-I domain of complement receptor 3, CD11b-I), both for the human and murine homologs. We observe 2 binding interfaces, on the LukG and the LukH protomers, and show that human CD11b-I induces LukGH oligomerization in solution. LukGH binds murine CD11b-I weakly and is inactive toward murine neutrophils. Using a LukGH variant engineered to bind mouse CD11b-I, we demonstrate that cytolytic activity does not only require binding but also receptor-dependent oligomerization. Our studies provide an unprecedented insight into bicomponent leukocidin-host receptor interaction, enabling the development of antitoxin approaches and improved animal models to explore these approaches.

Legend

Protein

Chemical

Disease

Primary Citation of related structures